Xeris Biopharma Holdings Inc (XERS)
1.855
+0.10
(+5.70%)
USD |
NASDAQ |
May 02, 16:00
1.855
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Market Cap: 275.01M for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 260.19M |
| April 30, 2024 | 259.44M |
| April 29, 2024 | 259.44M |
| April 26, 2024 | 259.44M |
| April 25, 2024 | 252.03M |
| April 24, 2024 | 260.93M |
| April 23, 2024 | 263.89M |
| April 22, 2024 | 263.89M |
| April 19, 2024 | 257.96M |
| April 18, 2024 | 260.93M |
| April 17, 2024 | 263.89M |
| April 16, 2024 | 266.86M |
| April 15, 2024 | 274.27M |
| April 12, 2024 | 283.16M |
| April 11, 2024 | 285.12M |
| April 10, 2024 | 278.10M |
| April 09, 2024 | 283.72M |
| April 08, 2024 | 283.72M |
| April 05, 2024 | 286.53M |
| April 04, 2024 | 287.93M |
| April 03, 2024 | 292.14M |
| April 02, 2024 | 293.55M |
| April 01, 2024 | 300.57M |
| March 28, 2024 | 310.40M |
| March 27, 2024 | 286.53M |
| Date | Value |
|---|---|
| March 26, 2024 | 287.93M |
| March 25, 2024 | 296.36M |
| March 22, 2024 | 294.95M |
| March 21, 2024 | 299.17M |
| March 20, 2024 | 307.59M |
| March 19, 2024 | 301.98M |
| March 18, 2024 | 299.17M |
| March 15, 2024 | 313.21M |
| March 14, 2024 | 299.17M |
| March 13, 2024 | 306.19M |
| March 12, 2024 | 310.40M |
| March 11, 2024 | 316.02M |
| March 08, 2024 | 330.07M |
| March 07, 2024 | 342.71M |
| March 06, 2024 | 348.32M |
| March 05, 2024 | 432.60M |
| March 04, 2024 | 426.98M |
| March 01, 2024 | 446.64M |
| February 29, 2024 | 431.89M |
| February 28, 2024 | 417.15M |
| February 27, 2024 | 432.35M |
| February 26, 2024 | 429.59M |
| February 23, 2024 | 415.77M |
| February 22, 2024 | 419.92M |
| February 21, 2024 | 414.39M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
55.98M
Minimum
Mar 18 2020
446.64M
Maximum
Mar 01 2024
250.55M
Average
253.16M
Median
Nov 08 2021
Market Cap Benchmarks
| Regeneron Pharmaceuticals Inc | 102.92B |
| Vanda Pharmaceuticals Inc | 269.28M |
| Adial Pharmaceuticals Inc | 7.218M |
| Kodiak Sciences Inc | 194.38M |
| Phathom Pharmaceuticals Inc | 570.61M |
Market Cap Related Metrics
| PS Ratio | 1.558 |
| Price | 1.855 |
| Earnings Yield | -23.72% |